Medical Patent Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Neose Technologies, Inc.
Neose Announces Departure of Chief Scientific Officer
January 25th, 2008
Neose Technologies, Inc. (NasdaqGM: NTEC) announced the departure of David A. Zopf, M.D., executive vice president and chief scientific officer, to pursue other opportunities. Shawn A. DeFrees, Ph.D., who has served as vice president, research and development since 2003, will assume Dr. Zopf's responsibilities. "We are grateful for the significant contributions David has made during his tenure at Neose. As an expert in glycobiology, David was integral in much of Neose's early technology development," said George J. Vergis, Neose president and chief executive officer. "David passes on his leadership responsibilities to a well-qualified and experienced...
Source: Medical Patent Business Week (2008-01-25)
|
